Samraat S. Raha, President and CEO at MYRIAD GENETICS INC (MYGN), bought 40,000 shares at $5.00 ($200K) on 2026-03-09, disclosed to the SEC on 2026-03-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.